An open study of dehydroepiandrosterone in systemic lupus erythematosus.
about
Dehydroepiandrosterone for systemic lupus erythematosusDehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly peopleGenetic regulation of serum cytokines in systemic lupus erythematosusDHEA: panacea or snake oil?Gender and risk of autoimmune diseases: possible role of estrogenic compounds.A novel dehydroepiandrosterone analog improves functional recovery in a rat traumatic brain injury model.Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review.Stress hormone-related psychopathology: pathophysiological and treatment implications.Dehydroepiandrosterone, a sex steroid metabolite in development for systemic lupus erythematosus.Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus.Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus.Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.Lupus nephritis: a review of the current pharmacological treatments.Prolactin and Dehydroepiandrosterone Levels in Women with Systemic Lupus Erythematosus: The Role of the Extrapituitary Prolactin Promoter Polymorphism at -1149G/TInfluence of sensitization and allergen provocation procedures on the development of allergen-induced bronchial hyperreactivity in conscious, unrestrained guinea-pigs.Androgen metabolism and inhibition of interleukin-1 synthesis in primary cultured human synovial macrophages.Emerging drug therapies for systemic lupus erythematosus.Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).Age- and sex-related patterns of serum interferon-alpha activity in lupus families.Update on emerging drug therapies for systemic lupus erythematosus.Management of systemic lupus erythematosus in Chinese patients.Immunomodulators in SLE: Clinical evidence and immunologic actions.Effects of prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot study.Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics of oral prednisone and cortisol suppression in normal women.Bromocriptine treatment of systemic lupus erythematosus.Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.Gonadotropin treatment restores in vitro interleukin-1beta and tumour necrosis factor-alpha production by stimulated peripheral blood mononuclear cells from patients with idiopathic hypogonadotropic hypogonadism.Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia.Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone
P2860
Q24243533-EFE4CADC-249D-4060-B8FB-F2A0E201B9A1Q24243786-B300A80F-C23E-42A3-B592-F969DB38FD31Q33682879-E059300C-AD30-495A-91BA-5C252610580DQ33698269-91E2FBFC-6EA2-4903-934B-3FEC195C0B7CQ33741159-A6AA3B2A-973E-4A9A-95A0-BB116A642382Q34205440-F5FEE16B-C791-4DC8-A107-CC7A80844FC9Q34351248-494D46F2-CC9B-4124-A24D-C82DC9D7E249Q35066496-1A9DC321-0D9E-41F8-B122-12D202B860E6Q35144010-1886EE49-3BE5-4448-BF09-15B70B9148ECQ35547547-780DB5AF-8E40-45C6-85AF-EDF17BB6AE8BQ35553688-9ACBF8AD-F084-4891-ADD8-577D933D07F5Q35636663-E42CC8E6-B98D-452E-8E6E-413AAB544466Q35925513-B08E3947-BAA4-41F3-A757-D936D0955E5CQ36259961-FB389F5E-F124-4194-84BE-9497D6539890Q36627704-4F87745F-525D-4398-AA07-BA40798E6C1FQ36627709-F37C9291-3A57-46A6-8997-E9A21A5F570AQ36634248-CE28BA3A-80AF-46C2-8B09-138D0A255F4AQ37300547-471FFEE6-B9C9-4EBC-B55D-CB15DAA2BDDFQ37312612-FF890159-3345-40E5-A776-E42352781669Q37690745-93068207-C868-44E5-B7D1-2D0A173D54AAQ37754815-3BF6DAC7-72D0-490C-A394-CEE317D7B710Q38883883-D5C9755D-C311-4705-95C2-5C03662F653EQ43041708-7797AEDC-A74A-4CCA-AE52-D7CDC72B4761Q43791584-C0DDA45B-7868-4733-94EB-851E2C0BAA1BQ43807946-4C513558-49A8-4244-976C-C0B653C34289Q44068958-7F5B90FB-ABD4-45E7-B84B-F6DE7E692DA3Q44406123-B1F4234B-FF62-4627-9577-B9418DEA5775Q51566103-969986EE-9F6D-45FF-A9DA-1BA2C5684F6BQ57601982-11637DC1-8878-4E0B-AFB2-474584600498
P2860
An open study of dehydroepiandrosterone in systemic lupus erythematosus.
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
An open study of dehydroepiandrosterone in systemic lupus erythematosus.
@ast
An open study of dehydroepiandrosterone in systemic lupus erythematosus.
@en
An open study of dehydroepiandrosterone in systemic lupus erythematosus.
@nl
type
label
An open study of dehydroepiandrosterone in systemic lupus erythematosus.
@ast
An open study of dehydroepiandrosterone in systemic lupus erythematosus.
@en
An open study of dehydroepiandrosterone in systemic lupus erythematosus.
@nl
prefLabel
An open study of dehydroepiandrosterone in systemic lupus erythematosus.
@ast
An open study of dehydroepiandrosterone in systemic lupus erythematosus.
@en
An open study of dehydroepiandrosterone in systemic lupus erythematosus.
@nl
P2093
P356
P1476
An open study of dehydroepiandrosterone in systemic lupus erythematosus.
@en
P2093
Engleman EG
McGuire JL
van Vollenhoven RF
P304
P356
10.1002/ART.1780370906
P577
1994-09-01T00:00:00Z